These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27812929)

  • 21. EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A.
    Wang K; Jiang X; Jiang Y; Liu J; Du Y; Zhang Z; Li Y; Zhao X; Li J; Zhang R
    J Exp Clin Cancer Res; 2023 Nov; 42(1):320. PubMed ID: 38008711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choline Regulates SOX4 through miR-129-5p and Modifies H3K27me3 in the Developing Cortex.
    Paules EM; Silva-Gomez JA; Friday WB; Zeisel SH; Trujillo-Gonzalez I
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic network of EZH2/SFRP1/Wnt in the epithelial-mesenchymal transition of laryngeal carcinoma cells.
    Chen W; Wang HT; Ji JF; Wang ZY; Shi T; Wu MH; Yu PJ
    Neoplasma; 2022 May; 69(3):680-690. PubMed ID: 35400167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression.
    Xie T; Tan M; Gao Y; Yang H
    Environ Toxicol; 2022 Aug; 37(8):1957-1967. PubMed ID: 35442568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.
    Liu F; Wu L; Wang A; Xu Y; Luo X; Liu X; Hua Y; Zhang D; Wu S; Lin T; He D; Wei G; Chen S
    Am J Transl Res; 2017; 9(8):3611-3622. PubMed ID: 28861152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EZH2-miRNA Positive Feedback Promotes Tumor Growth in Ovarian Cancer.
    Liu T; Cai J; Cai J; Wang Z; Cai L
    Front Oncol; 2020; 10():608393. PubMed ID: 33718109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HSP90-Dependent Upregulation of EZH2 Promotes Hypoxia/Reoxygenation-Induced Pyroptosis by Inhibiting miR-22 in Endothelial Cells.
    Deng P; Hu H
    J Inflamm Res; 2023; 16():2615-2630. PubMed ID: 37360624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone methyltransferase EZH2 in proliferation, invasion, and migration of fibroblast-like synoviocytes in rheumatoid arthritis.
    Chang L; Zhou R
    J Bone Miner Metab; 2022 Mar; 40(2):262-274. PubMed ID: 35083555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EZH2 promotes the expression of LPA1 by mediating microRNA-139 promoter methylation to accelerate the development of ovarian cancer.
    Wu D; Wu F; Li B; Huang W; Wang D
    Cancer Cell Int; 2020 Nov; 20(1):551. PubMed ID: 33292225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-β-MTA1-SMAD7-SMAD3-SOX4-EZH2 Signaling Axis Promotes Viability, Migration, Invasion and EMT of Hepatocellular Carcinoma Cells.
    Zhang K; Fang T; Shao Y; Wu Y
    Cancer Manag Res; 2021; 13():7087-7099. PubMed ID: 34531686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
    Au SL; Wong CC; Lee JM; Wong CM; Ng IO
    PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A TGF-β-MTA1-SOX4-EZH2 signaling axis drives epithelial-mesenchymal transition in tumor metastasis.
    Li L; Liu J; Xue H; Li C; Liu Q; Zhou Y; Wang T; Wang H; Qian H; Wen T
    Oncogene; 2020 Mar; 39(10):2125-2139. PubMed ID: 31811272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circular RNA circ_0011385 promotes cervical cancer progression through competitively binding to miR-149-5p and up-regulating SOX4 expression.
    Xu AL; Wang WS; Zhao MY; Sun JN; Chen XR; Hou JQ
    Kaohsiung J Med Sci; 2021 Dec; 37(12):1058-1068. PubMed ID: 34369654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-129-5p modulates epithelial-to-mesenchymal transition by targeting SIP1 and SOX4 during peritoneal dialysis.
    Xiao L; Zhou X; Liu F; Hu C; Zhu X; Luo Y; Wang M; Xu X; Yang S; Kanwar YS; Sun L
    Lab Invest; 2015 Jul; 95(7):817-832. PubMed ID: 25961171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
    Zhang L; Wu X; Li Y; Teng X; Zou L; Yu B
    Autoimmunity; 2021 Mar; 54(2):88-96. PubMed ID: 33622094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4.
    Li Y; Chen P; Zu L; Liu B; Wang M; Zhou Q
    Am J Cancer Res; 2016; 6(2):127-40. PubMed ID: 27186391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
    Guo M; Lin B; Li G; Lin J; Jiang X
    J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-204 targets SOX4 to inhibit metastasis of lung adenocarcinoma.
    Hu WB; Wang L; Huang XR; Li F
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1553-1562. PubMed ID: 30840278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-181a upregulation is associated with epithelial-to-mesenchymal transition (EMT) and multidrug resistance (MDR) of ovarian cancer cells.
    Li L; Xu QH; Dong YH; Li GX; Yang L; Wang LW; Li HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2004-10. PubMed ID: 27249598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells.
    Shen CJ; Cheng YM; Wang CL
    J Drug Target; 2017 Aug; 25(7):637-644. PubMed ID: 28296507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.